Pol F. Boudes

Executive

US·SEC (Form 4)

Protalix BioTherapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 04 Sept 2025 for Protalix BioTherapeutics, Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Pol F. Boudes: trading record in brief

Our data holds just one disclosure by Pol F. Boudes, dated 4 September 2025, reporting a share grant in Protalix BioTherapeutics, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Pol F. Boudes

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Protalix BioTherapeutics, Inc. (US)

Declarations1 total

◆

Pol F. Boudes

DirectorExecutives3 Sept 2025Protalix BioTherapeutics, Inc.

0SEC

7,500 sharesCommon StockSEC:0001415889-25-023705:0

1 of 1 declaration

Pol F. Boudes

Insider track record

Pol F. Boudes: trading record in brief

Companies and markets linked to Pol F. Boudes

Related entities

Pol F. Boudes

Insider track record

Pol F. Boudes: trading record in brief

Companies and markets linked to Pol F. Boudes

Related entities